AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $218.04
-
Support level$207.99
-
Resistance level$222.63
-
Beta0.4
-
RSI (14-day)29.7
- Volatility is forecast to fall over the next month.
- ABBV is above its 200-day moving average, providing a measure of support for long positions.
- With RSI < 30, ABBV is oversold. Odds slightly favor a short-term price reversal.
- Price crossed below 50-day moving average this week - a bearish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $164.99 | $244.38 | 71.0% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $199.55 | $222.37 | $228.64 | $227.53 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week5.8%
-
In the next month14.2%
-
In the next year55.4%
| Period | Value |
|---|---|
| Historical (5 year) | 23.0% |
| Last month | 32.5% |
| Current estimate | 21.2% |
| Next month forecast | 25.2% |